Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jantima Tanboon

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Plos One|August 19, 2020
HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositisMunenori Oyama, Yuko Ohnuki, Michio Inoue, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 10, 2016
Impact of histopathological transformation and overall survival in patients with progressive anaplastic gliomaAllen L Ho, Matthew J Koch, Shota Tanaka, et al.
Brain Pathology (Zurich, Switzerland)|August 13, 2023
Exploiting nanopore sequencing for characterization and grading of IDH-mutant gliomasThidathip Wongsurawat, Piroon Jenjaroenpun, Panatna Anekwiang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 2, 2021
Deep convolutional neural network-based algorithm for muscle biopsy diagnosisYoshinori Kabeya, Mariko Okubo, Sho Yonezawa, et al.
British Journal of Cancer|May 20, 2017
Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcomaLeanne de Kock, Barbara Rivera, Timothée Revil, et al.
Rheumatology (Oxford, England)|June 21, 2021
Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rashYuki Ichimura, Risa Konishi, Miwako Shobo, et al.
The Journal of Dermatology|December 30, 2021
Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein propertiesYuki Ichimura, Risa Konishi, Miwako Shobo, et al.
JAMA Neurology|April 21, 2020
Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 AutoantibodiesMichio Inoue, Jantima Tanboon, Shinya Hirakawa, et al.
Science Translational Medicine|May 26, 2017
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activationDavid P Kodack, Vasileios Askoxylakis, Gino B Ferraro, et al.
American Journal of Human Genetics|November 20, 2020
Pathogenic Variants in the Myosin Chaperone UNC-45B Cause Progressive Myopathy with Eccentric CoresSandra Donkervoort, Carl E Kutzner, Ying Hu, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Plos One|August 19, 2020
HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositisMunenori Oyama, Yuko Ohnuki, Michio Inoue, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 10, 2016
Impact of histopathological transformation and overall survival in patients with progressive anaplastic gliomaAllen L Ho, Matthew J Koch, Shota Tanaka, et al.
Brain Pathology (Zurich, Switzerland)|August 13, 2023
Exploiting nanopore sequencing for characterization and grading of IDH-mutant gliomasThidathip Wongsurawat, Piroon Jenjaroenpun, Panatna Anekwiang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 2, 2021
Deep convolutional neural network-based algorithm for muscle biopsy diagnosisYoshinori Kabeya, Mariko Okubo, Sho Yonezawa, et al.
British Journal of Cancer|May 20, 2017
Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcomaLeanne de Kock, Barbara Rivera, Timothée Revil, et al.
Rheumatology (Oxford, England)|June 21, 2021
Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rashYuki Ichimura, Risa Konishi, Miwako Shobo, et al.
The Journal of Dermatology|December 30, 2021
Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein propertiesYuki Ichimura, Risa Konishi, Miwako Shobo, et al.
JAMA Neurology|April 21, 2020
Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 AutoantibodiesMichio Inoue, Jantima Tanboon, Shinya Hirakawa, et al.
Science Translational Medicine|May 26, 2017
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activationDavid P Kodack, Vasileios Askoxylakis, Gino B Ferraro, et al.
American Journal of Human Genetics|November 20, 2020
Pathogenic Variants in the Myosin Chaperone UNC-45B Cause Progressive Myopathy with Eccentric CoresSandra Donkervoort, Carl E Kutzner, Ying Hu, et al.
Pageof 6